Mesa Laboratories, Inc. (MLAB)
121.48
+0.61
(+0.50%)
USD |
NASDAQ |
Sep 14, 16:00
120.90
-0.58
(-0.48%)
After-Hours: 07:46
Mesa Laboratories Enterprise Value : 810.43M for Sept. 14, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 810.43M |
| September 11, 2026 | 807.02M |
| September 10, 2026 | 807.24M |
| September 09, 2026 | 824.03M |
| September 08, 2026 | 823.08M |
| September 04, 2026 | 845.69M |
| September 03, 2026 | 849.88M |
| September 02, 2026 | 861.75M |
| September 01, 2026 | 832.76M |
| August 31, 2026 | 846.19M |
| August 28, 2026 | 853.02M |
| August 27, 2026 | 850.56M |
| August 26, 2026 | 842.16M |
| August 25, 2026 | 843.28M |
| August 24, 2026 | 826.33M |
| August 21, 2026 | 828.79M |
| August 20, 2026 | 797.40M |
| August 19, 2026 | 800.59M |
| August 18, 2026 | 734.67M |
| August 17, 2026 | 732.99M |
| August 14, 2026 | 724.03M |
| August 13, 2026 | 764.10M |
| August 12, 2026 | 761.86M |
| August 11, 2026 | 753.08M |
| August 10, 2026 | 699.30M |
| Date | Value |
|---|---|
| August 07, 2026 | 705.06M |
| August 06, 2026 | 695.89M |
| August 05, 2026 | 704.90M |
| August 04, 2026 | 696.62M |
| August 03, 2026 | 715.03M |
| July 31, 2026 | 694.77M |
| July 30, 2026 | 696.06M |
| July 29, 2026 | 688.33M |
| July 28, 2026 | 696.39M |
| July 27, 2026 | 677.76M |
| July 24, 2026 | 676.25M |
| July 23, 2026 | 695.55M |
| July 22, 2026 | 682.23M |
| July 21, 2026 | 676.30M |
| July 20, 2026 | 671.60M |
| July 17, 2026 | 678.71M |
| July 16, 2026 | 687.10M |
| July 15, 2026 | 660.47M |
| July 14, 2026 | 660.24M |
| July 13, 2026 | 661.98M |
| July 10, 2026 | 665.67M |
| July 09, 2026 | 664.44M |
| July 08, 2026 | 641.89M |
| July 07, 2026 | 668.75M |
| July 06, 2026 | 704.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 43.58B |
| Bio-Rad Laboratories, Inc. | 9.605B |
| Bruker Corp. | 9.680B |
| Danaher Corp. | 166.39B |
| Harvard Bioscience, Inc. | 74.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.83M |
| Revenue (Quarterly) | 60.14M |
| Total Expenses (Quarterly) | 57.31M |
| EPS Diluted (Quarterly) | 0.4916 |
| Gross Profit Margin (Quarterly) | 57.87% |
| Profit Margin (Quarterly) | 4.71% |
| Earnings Yield | 0.70% |
| Operating Earnings Yield | 3.30% |
| Normalized Earnings Yield | 0.6958 |